0001209191-23-034850.txt : 20230606
0001209191-23-034850.hdr.sgml : 20230606
20230606182244
ACCESSION NUMBER: 0001209191-23-034850
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230602
FILED AS OF DATE: 20230606
DATE AS OF CHANGE: 20230606
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Saad Mark E
CENTRAL INDEX KEY: 0001295913
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37635
FILM NUMBER: 23997263
BUSINESS ADDRESS:
BUSINESS PHONE: 858-458-0900
MAIL ADDRESS:
STREET 1: C/O CYTORI THERAPEUTICS, INC.
STREET 2: 3020 CALLAN ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axsome Therapeutics, Inc.
CENTRAL INDEX KEY: 0001579428
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 454241907
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE WORLD TRADE CENTER, 22ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
BUSINESS PHONE: (212) 332-3241
MAIL ADDRESS:
STREET 1: ONE WORLD TRADE CENTER, 22ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-02
0
0001579428
Axsome Therapeutics, Inc.
AXSM
0001295913
Saad Mark E
C/O AXSOME THERAPEUTICS, INC.
ONE WORLD TRADE CENTER, 22ND FLOOR
NEW YORK
NY
10007
1
0
0
0
0
Stock Option (Right to Buy)
74.12
2023-06-02
4
A
0
5681
0.00
A
2024-06-02
2033-06-02
Common Stock
5681
5681
D
The option vests in full on the one-year anniversary of the date of grant, June 2, 2024.
/S/ Herriot Tabuteau, M.D., Attorney-in-Fact
2023-06-06